MAGE-A3 expression in HNSCC is associated with decreased overall survival, since in conventional therapy, the immune system appears unable to counteract the aggressiveness of MAGE-positive tumors (127). Here, MAGEA3 is linked to head and neck squamous cell carcinoma.